Hematology & Oncology Doctors in Gettysburg, PA Accepting Medicare

8 Hematology & Oncology doctors found. Showing 1 - 8

Dr. Raymond Butler Weiss, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 20 Expedition Trail, Suite 101, Gettysburg, PA 17325 Phone: 717-334-4033    Fax: 717-334-5599

Dr. Howard Ira Saiontz, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 20 Expedition Trl, Suite 101, Gettysburg, PA 17325 Phone: 717-334-4033    Fax: 717-334-5599

Dr. Douglas Roscoe Jones, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 20 Expedition Trail Suite 101, Satish A. Shah, M.d., P.c., Gettysburg, PA 17325 Phone: 717-334-4033    Fax: 717-334-5599

Dr. Uzoma Nwakuche, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 40 V Twin Dr Ste 104, Gettysburg, PA 17325 Phone: 717-339-2560    Fax: 717-334-0929

Dr. Satish A Shah, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 20 Expedition Trl, Suite 101, Gettysburg, PA 17325 Phone: 717-334-4033    Fax: 717-334-5599

Dr. Ikechukwu Immanuel Akunyili, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 40 V Twin Dr, Suite 104, Gettysburg, PA 17325 Phone: 717-339-2560    Fax: 717-334-0929

Neal Shah, M.D. Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 20 Expedition Trl Ste 101, Gettysburg, PA 17325 Phone: 717-334-4033    Fax: 717-334-5599

Anshuma Rana, MD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 40 V Twin Dr Ste 104, Gettysburg, PA 17325 Phone: 717-339-2560    Fax: 717-334-0929

News Archive

Ryan & Maniskas commence investigation of BioSphere Medical

Ryan & Maniskas, LLP has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by members of the Board of Directors of BioSphere Medical, Inc. in connection with their actions in causing BioSphere Medical to enter into a merger agreement with Merit Medical System, Inc. and Merit BioAcquisition Co., a wholly-owned subsidiary of Merit Medical pursuant to which BioSphere Medical will merge with and into Merit BioAcquisition Co.

World's first engineered T cell receptor trial opens with new cellular therapy for HIV

Researchers at Adaptimmune Limited and the University of Pennsylvania School of Medicine, have announced the approval of an Investigational New Drug (IND) application from the US Food and Drug Administration (FDA) and opening for enrolment of the first ever study using patients' cells carrying an engineered T cell receptor to treat HIV (SL9 HA-GAG-TCR). The trial may have important implications in the development of new treatments for HIV potentially slowing – or even preventing – the onset of AIDS.

As constituents clamor for ivermectin, Republican politicians embrace the cause

When state senators in South Carolina held two hearings in September about covid-19 treatments, they got an earful on the benefits of ivermectin — which many of the lawmakers echoed, sharing experiences of their own loved ones.

SironRX completes enrollment in Cohort 1 to study JVS-100 for wound healing, scar prevention

SironRX Therapeutics Inc., a privately-held, clinical-stage biotechnology company developing novel regenerative therapies to prevent scarring and promote dermal wound repair, is pleased to report that it has completed enrollment of patients in Cohort 1 of its placebo-controlled, randomized, dose escalation double-blind clinical study evaluating the safety and efficacy of JVS-100 to reduce scar formation and improve wound healing in patients receiving surgical sternotomy incisions.

Crowding essentially 'blends' nearby objects together and makes the world appear more regular

As you read this, you may notice that the word directly in front of you is clear, but all the surrounding words are hard to make out. For most people, this effect - known as 'crowding' - is not a problem. However, for the millions of people worldwide who have lost their central vision through eye disease such as macular degeneration, it can make everyday tasks such as reading or recognising friends a challenge.

Read more Medical News

› Verified 4 days ago